![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
The Efficacy of Recombinant Human Follicle Stimulating Hormone (rhFSH) in Controlled Ovarian Hyperstimulation for In Vitro Fertilization and Embryo Transfer. |
Jung Hoon Kim, Sung Hoon Kim, Eun Joo Park, Suk Ho Hong, Hee Dong Chae, Byung Moon Kang, Yoon Suk Jang |
Obstet Gynecol Sci. 2001;44(1):36-42. Published online January 1, 2001 |
The clinical efficacy and safety of recombinant human follicle-stimulating hormone(RHFSH) in chinese in vitro fertilization-embryo transfer(IVF-ET) patients from a randomized controlled trial (RCT) (phase III) A randomized, assessor-blind, multicentre study to investigate the efficacy and efficiency of a starting dose of 100IU or 200IU of recombinant follicle stimulating hormone (Puregon®) in women undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer treatment The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization A Multi-Center Study Comparing the Efficacy of Recombinant Human Follicle Stimulating Hormone (r-hFSH, Gonal-F®) Versus r-hFSH Plus Recombinant Human Luteinizing Hormone (r-hLH, Lhadi®) in Patients Undergoing Controlled Ovarian Hyperstimulation (COH) for Assisted Reproductive Technologies (ART) Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer Positive association between reduced ovarian responsiveness to recombinant human follicle stimulating hormone (rhFSH) therapy for in vitro fertilization (IVF) and diminished intrafollicular testosterone (T) and estradiol (E2) levels Cetrorelix/ganirelix/recombinant follicle stimulating hormone/triptorelin Chorionic gonadotropin/recombinant follicle stimulating hormone |